The lyophilized versus liquid peptide comparison illustrates the kind of technical nuance that matters when communicating specifications across language barriers
Practical Prevention Strategies for GLP-1 Users Intentional hydration is the first-line defense against UTI during semaglutide therapy
Im pleased to share that the first participants have been dosed in two new studies of PF3944, our investigational ultra-long-acting GLP-1 receptor agonist (GLP-1 RA): VESPER-6, our Phase 3 pivotal trial evaluating monthly dosing, and SOLIS-1, a Phase 2b umbrella study evaluating PF3945 alone and in combination with our investigational ultra-long-acting amylin analog, PF3945
Semaglutide functions as a synthetic version of GLP-1, binding to receptors in both the brain and gastrointestinal tract
Having more options available to patients is a good thing, says Daniel Drucker, an endocrinologist at the University of Toronto whose research paved the way for GLP-1 drugs but who was not involved in the new studies
